AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H601-H607, 2004. First published March 25, 2004; doi:10.1152/ajpheart.00122.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/H601    most recent
00122.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LaDisa, J. F.
Right arrow Articles by Kersten, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LaDisa, J. F., Jr.
Right arrow Articles by Kersten, J. R.

Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia

John F. LaDisa, Jr.,1,4 John G. Krolikowski,1 Paul S. Pagel,1,4 David C. Warltier,1,2,3,4 and Judy R. Kersten1,3

Departments of 1Anesthesiology, 2Division of Cardiovascular Diseases, Department of Medicine, and 3Pharmacology and Toxicology, the Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee 53226; and the Department of Biomedical Engineering, 4Marquette University, Milwaukee, Wisconsin 53201

Submitted 5 February 2004 ; accepted in final form 19 March 2004

We tested the hypothesis that glucose-insulin-potassium (GIK)-induced protection against myocardial infarction depends on ATP-dependent K+ (KATP) channel activation and is abolished by hyperglycemia before the ischemia. Dogs were subjected to a 60-min coronary artery occlusion and 3-h reperfusion in the absence or presence of GIK (25% dextrose; 50 IU insulin/l; 80 mM/l KCl infused at 1.5 ml·kg–1·h–1) beginning 75 min before coronary artery occlusion or 5 min before reperfusion. The role of KATP channels was evaluated by pretreatment with glyburide (0.1 mg/kg). The efficacy of GIK was investigated with increases in blood glucose (BG) concentrations to 300 or 600 mg/dl or experimental diabetes (alloxan/streptozotocin). Infarct size (IS) was 29 ± 2% of the area at risk in control experiments. GIK decreased (P < 0.05) IS when administered beginning 5 min before reperfusion. This protective action was independent of BG (13 ± 2 and 12 ± 2% of area at risk; BG = 80 or 600 mg/dl, respectively) but was abolished in dogs receiving glyburide (30 ± 4%), hyperglycemia before ischemia (27 ± 4%), or diabetes (25 ± 3%). IS was unchanged by GIK when administered before ischemia independent of BG (31 ± 3, 27 ± 2, and 35 ± 3%; BG = 80, 300, and 600 mg/dl, respectively). The insulin component of GIK promotes cardioprotection by KATP channel activation. However, glucose decreases KATP channel activity, and this effect predominates when hyperglycemia is present before ischemia.

diabetes; hyperglycemia; myocardial infarction



Address for reprint requests and other correspondence: J. R. Kersten, Medical College of Wisconsin, MEB-M4280, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (E-mail: jkersten{at}mcw.edu).




This article has been cited by other articles:


Home page
CirculationHome page
R. A. Kloner and R. W. Nesto
Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection
Circulation, May 13, 2008; 117(19): 2523 - 2533.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. W. Quinn, D. Pagano, R. S. Bonser, S. J. Rooney, T. R. Graham, I. C. Wilson, B. E. Keogh, J. N. Townend, M. E. Lewis, P. Nightingale, et al.
Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. W. Quinn, D. Pagano, and R. S. Bonser
Glucose and Insulin Influences on Heart and Brain in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2005; 9(2): 173 - 178.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.